{
    "organizations": [],
    "uuid": "6435937efebd5ea58ab572669ab0504119a9e8d9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fibrogen-granted-fast-track-design/brief-fibrogen-granted-fast-track-designation-by-u-s-fda-for-pamrevlumab-treatment-of-patients-idUSASB0C89K",
    "ord_in_thread": 0,
    "title": "Fibrogen Granted Fast Track Designation By U.S. FDA For Pamrevlumab Treatment Of Patients",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Fibrogen Inc:\n* FIBROGEN GRANTED FAST TRACK DESIGNATION BY U.S. FDA FOR PAMREVLUMAB TREATMENT OF PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER Source text for Eikon: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-03-01T20:17:00.000+02:00",
    "crawled": "2018-03-02T19:59:50.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "fibrogen",
        "inc",
        "fibrogen",
        "granted",
        "fast",
        "track",
        "designation",
        "fda",
        "pamrevlumab",
        "treatment",
        "patient",
        "locally",
        "advanced",
        "unresectable",
        "pancreatic",
        "cancer",
        "source",
        "text",
        "eikon"
    ]
}